Welcome to the 2010 Leaders' Forum

Two sector-leading meetings co-located once again in 2010 – the 15th Phacilitate R&D Leaders’ Forum and the 5th Phacilitate Oncology Leaders’ Forum.

Participants in the 2009 event said:

"Once again a well-run conference that was an effective use of my time, with senior thought-leaders discussing relevant topics and ample time for quality networking"
Dr Dianne C. Kikta, Vice President, Global Clinical Strategic Resourcing, Pfizer, Inc

"Great organization which lead to frank, open discussions and friendly networking"
Dr Estuardo Aguilar-Cordova, President & CEO, Advantagene, Inc

"A high impact event featuring the industry’s top performers"
Dr David Hughes, Publisher, Future Medicine

"Excellent forum to discuss current issues. Highly interactive and open"
Dr Thomas W. Davis, Associate Director of Oncology, PTC Therapeutics

"Very focused and good level of speakers"
Ms Catherine Indekeu, Vice President, Business Development, IDDI

"The day 1 stakeholders meeting was particularly enlightening with multiple perspectives in the healthcare debate"
Dr Thomas C. Reynolds, Chief Medical Officer, Seattle Genetics

R&D Leaders' Forum Recognized as the leader by the leaders Phacilitate R&D Leaders’ Forums are the essential annual events for the very highest levels of R&D management from across the life sciences sector. Their interactive programs focus on the discussion of solutions to the core challenges facing R&D leaders as they seek to improve productivity, quality and efficiency at all stages of the drug discovery and development pipeline.	Oncology Leaders' Forum Targeting success Phacilitate Oncology Leaders’ Forums are the events of choice for senior level R&D and business development executives driving the development and launch of novel cancer therapeutics of all classes. The focus is on overcoming the key clinical and regulatory challenges being faced in the development and launch of oncology drugs, as well as on the discussion of how the sector can react to the evolving marketplace.
Both conferences consist of a three-day program made up of plenary sessions, breakout workshops and panel discussions, designed to maximize knowledge exchange between all participants. In November 2010, the two conferences will again run in parallel. You will be able to attend sessions during both programs and enjoy superb networking opportunities in the shared exhibition area.

©Copyright Phacilitate Limited 2009